GeNeuro

GeNeuro is a company listed under the stock ticker GNRO (CH).

View the org chart displaying its 11 main executives

Most searched biographies at GeNeuro

• Jesus Martin-Garcia, Chief Executive Officer and Director
• Eric Falcand, Director
• Giacomo Di Nepi, Director

Popular executive movements at GeNeuro

• Anke Post has joined the company as Chief Medical Officer  (posted on January 7 2024).
• David Leppert, Chief Medical Officer, has left the company  (posted on January 7 2024).

Create your alert
to follow the executive moves at GeNeuro.

GeNeuro has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by GeNeuro

• GeNeuro - News & Media
• Press releases
• Press releases

Social media about GeNeuro

• GeNeuro on Wikipedia, Google News & Yahoo Finance
• GeNeuro on LinkedIn, Twitter & YouTube

Contact by email its executives including Jesus Martin-Garcia

Call GeNeuro at +41 22...

View the org chart

Register to receive your alert

Report an error